Delsym is the only FDA-approved 12-hour non-prescription liquid cough suppressant CHESTER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) today announced that the Food and Drug Administration (FDA) approved its supplemental New Drug Application for a grape-flavored formulation of Delsym Extended-Release Suspension on Friday, Sept. 28, 2007. The Company will immediately commence distribution of grape Delsym product to its trade customers. Delsym is the first and only over-the-counter (OTC) liquid that controls cough for a full 12 hours with a single dose, providing all day or all night cough suppression with each dose. Delsym's patented single-ingredient formula delivers great tasting medicine in orange and now new grape flavors for both children and adults. About Adams Respiratory Therapeutics, Inc. Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders. DATASOURCE: Adams Respiratory Therapeutics, Inc. CONTACT: Janet M. Barth, Adams Respiratory Therapeutics, Inc., +1-908-879-2428 Web site: http://www.adamsrt.com/

Copyright